COVID-19 Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Prefilled Syringe, Patches), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2027
This report can be delivered to the clients within a timeline of 10-12 business days post order
COVID-19 Drug Delivery Devices Market Growth & Trends
The global COVID-19 drug delivery devices market size is expected to reach USD 2.15 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2022 to 2027.
The market is expected to gain significant traction over the forecast period as various nasal drug delivery technologies for administrating COVID-19 vaccines are under clinical and pre-clinical development. For instance, in April 2020, Verndari, Inc. initiated the preclinical trials for coronavirus vaccine using its patented microneedle array dermal patch- VaxiPatch.
The nasal, dermal, and needle-free are the alternatives to the traditional syringe vaccine platforms. These devices potentially reduce or eliminate needlestick injuries and reduce the associated treatment costs. According to the research article published in PLUS ONE Journal, November 2019, needlestick injury (NSI) is among a major burden in medical settings, leading to the transmission of infectious diseases, such as hepatitis and HIV.
According to the article published in StatPearls publishing, December 2019, around 2-4% healthcare workers develop hepatitis C after suffering from needlestick injuries. The CDC further stated that needlestick injuries cost an estimated USD 3,042 per victim annually in U.S.
COVID-19 Drug Delivery Devices Market Report Highlights
COVID-19 Drug Delivery Devices Market Growth & Trends
The global COVID-19 drug delivery devices market size is expected to reach USD 2.15 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2022 to 2027.
The market is expected to gain significant traction over the forecast period as various nasal drug delivery technologies for administrating COVID-19 vaccines are under clinical and pre-clinical development. For instance, in April 2020, Verndari, Inc. initiated the preclinical trials for coronavirus vaccine using its patented microneedle array dermal patch- VaxiPatch.
The nasal, dermal, and needle-free are the alternatives to the traditional syringe vaccine platforms. These devices potentially reduce or eliminate needlestick injuries and reduce the associated treatment costs. According to the research article published in PLUS ONE Journal, November 2019, needlestick injury (NSI) is among a major burden in medical settings, leading to the transmission of infectious diseases, such as hepatitis and HIV.
According to the article published in StatPearls publishing, December 2019, around 2-4% healthcare workers develop hepatitis C after suffering from needlestick injuries. The CDC further stated that needlestick injuries cost an estimated USD 3,042 per victim annually in U.S.
COVID-19 Drug Delivery Devices Market Report Highlights
- North America is anticipated to capture the largest share in 2021 owing to growing investment by government organizations for vaccine development, surge in COVID-19 cases, and intensive R&D conducted by the key players
- By product, the prefilled syringe segment is expected to dominate the market in 2021 as these cost-effective delivery devices will be manufactured in bulk quantities for vaccine administration and will be the first among the approved products
- By route of administration, the parenteral segment is expected to dominate the market in 2021 as the injection devices are affordable and are among the easily available devices
- By distribution channel, the hospital pharmacies segment is expected to account for the largest market share in 2021 as these drug delivery devices require medical assistance for vaccine administration
- Market players are adopting several strategies such as significant investment in research and development and product innovation via collaborations with technology providers and universities to gain a significant share in the global market.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. By Product
1.1.2. By Route of Administration
1.1.3. By Distribution Channel
1.1.4. Country scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Route of Administration outlook
2.2.3. Distribution Channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. COVID-19 DRUG DELIVERY DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growth in government funding to support vaccine production
3.4.1.2. Development of novel non-invasive drug delivery technologies
3.4.1.3. Increasing collaborations among universities and market players
3.4.2. Market restraint analysis
3.4.2.1. High research and development costs
3.4.2.2. Limited vaccine production facilities and lack of data supporting efficacy
3.5. COVID-19 Drug Delivery Devices Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
CHAPTER 4. COVID-19 DRUG DELIVERY DEVICES MARKET: BY PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Prefilled syringe
4.1.2. Needle-free injectors
4.1.3. Inhalers
4.1.4. Patches
4.2. Product Market Share, 2020 & 2027
4.3. Segment Dashboard
4.4. Global COVID-19 Drug Delivery Devices Market, by Product Outlook
4.4.1. Prefilled syringe
4.4.1.1. Prefilled syringe market estimates and forecast, 2016 - 2027 (USD Million)
4.4.2. Needle-free injectors
4.4.2.1. Needle-free injectors market estimates and forecast, 2016 - 2027 (USD Million)
4.4.3. Inhalers
4.4.3.1. Inhalers market estimates and forecast, 2016 - 2027 (USD Million)
4.4.4. Patches
4.4.4.1. Patches market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 5. COVID-19 DRUG DELIVERY DEVICES MARKET: BY ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Parenteral
5.1.2. Nasal
5.1.3. Dermal
5.2. By Route of Administration Market Share, 2020 & 2027
5.3. Segment Dashboard
5.4. Global COVID-19 Drug Delivery Devices Market, by Route of Administration Outlook
5.4.1. Parenteral
5.4.1.1. Parenteral market estimates and forecast, 2016 - 2027 (USD Million)
5.4.2. Nasal
5.4.2.1. Nasal market estimates and forecast, 2016 - 2027 (USD Million)
5.4.3. Dermal
5.4.3.1. Dermal market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 6. COVID-19 DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Hospital pharmacies
6.1.2. Retail pharmacies
6.1.3. Online pharmacies
6.2. By Distribution Channel Market Share, 2020 & 2027
6.3. Segment Dashboard
6.4. Global COVID-19 Drug Delivery Devices Market, by Distribution Channel Outlook
6.4.1. Hospital pharmacies
6.4.1.1. Hospital pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
6.4.2. Retail pharmacies
6.4.2.1. Retail pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
6.4.3. Online pharmacies
6.4.3.1. Online pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 7. COVID-19 DRUG DELIVERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Country Market Share Analysis, 2020 & 2027
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
7.9.5. South Korea
7.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
7.9.6. Australia
7.9.6.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
7.10.4. Argentina
7.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
7.10.5. Colombia
7.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
7.11.4. UAE
7.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. AstraZeneca
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Johnson & Johnson
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Serum Institute of India
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. GlaxoSmithKline plc
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Moderna
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Bharat Biotech
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. PharmaJet
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Pfizer
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Novavax, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. By Product
1.1.2. By Route of Administration
1.1.3. By Distribution Channel
1.1.4. Country scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Route of Administration outlook
2.2.3. Distribution Channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. COVID-19 DRUG DELIVERY DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growth in government funding to support vaccine production
3.4.1.2. Development of novel non-invasive drug delivery technologies
3.4.1.3. Increasing collaborations among universities and market players
3.4.2. Market restraint analysis
3.4.2.1. High research and development costs
3.4.2.2. Limited vaccine production facilities and lack of data supporting efficacy
3.5. COVID-19 Drug Delivery Devices Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
CHAPTER 4. COVID-19 DRUG DELIVERY DEVICES MARKET: BY PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Prefilled syringe
4.1.2. Needle-free injectors
4.1.3. Inhalers
4.1.4. Patches
4.2. Product Market Share, 2020 & 2027
4.3. Segment Dashboard
4.4. Global COVID-19 Drug Delivery Devices Market, by Product Outlook
4.4.1. Prefilled syringe
4.4.1.1. Prefilled syringe market estimates and forecast, 2016 - 2027 (USD Million)
4.4.2. Needle-free injectors
4.4.2.1. Needle-free injectors market estimates and forecast, 2016 - 2027 (USD Million)
4.4.3. Inhalers
4.4.3.1. Inhalers market estimates and forecast, 2016 - 2027 (USD Million)
4.4.4. Patches
4.4.4.1. Patches market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 5. COVID-19 DRUG DELIVERY DEVICES MARKET: BY ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Parenteral
5.1.2. Nasal
5.1.3. Dermal
5.2. By Route of Administration Market Share, 2020 & 2027
5.3. Segment Dashboard
5.4. Global COVID-19 Drug Delivery Devices Market, by Route of Administration Outlook
5.4.1. Parenteral
5.4.1.1. Parenteral market estimates and forecast, 2016 - 2027 (USD Million)
5.4.2. Nasal
5.4.2.1. Nasal market estimates and forecast, 2016 - 2027 (USD Million)
5.4.3. Dermal
5.4.3.1. Dermal market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 6. COVID-19 DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.1.1. Hospital pharmacies
6.1.2. Retail pharmacies
6.1.3. Online pharmacies
6.2. By Distribution Channel Market Share, 2020 & 2027
6.3. Segment Dashboard
6.4. Global COVID-19 Drug Delivery Devices Market, by Distribution Channel Outlook
6.4.1. Hospital pharmacies
6.4.1.1. Hospital pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
6.4.2. Retail pharmacies
6.4.2.1. Retail pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
6.4.3. Online pharmacies
6.4.3.1. Online pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 7. COVID-19 DRUG DELIVERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Country Market Share Analysis, 2020 & 2027
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
7.9.5. South Korea
7.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
7.9.6. Australia
7.9.6.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
7.10.4. Argentina
7.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
7.10.5. Colombia
7.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
7.11.4. UAE
7.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. AstraZeneca
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Johnson & Johnson
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Serum Institute of India
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. GlaxoSmithKline plc
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Moderna
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Bharat Biotech
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. PharmaJet
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Pfizer
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Novavax, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 North America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 3 North America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 4 North America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 5 North America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 6 U.S. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 7 U.S. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 8 U.S. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 9 Canada COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 10 Canada COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 11 Canada COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 12 Europe COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 13 Europe COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 14 Europe COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 15 Europe COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 16 U.K. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 17 U.K. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 18 U.K. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 19 Germany COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 20 Germany COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 21 Germany COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 22 Italy COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 23 Italy COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 24 Italy COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 25 Spain COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 26 Spain COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 27 Spain COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 28 France COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 29 France COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 30 France COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 31 Asia Pacific COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 32 Asia Pacific COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 33 Asia Pacific COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 34 Asia Pacific COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 35 Japan COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 36 Japan COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 37 Japan COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 38 China COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 39 China COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 40 China COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 41 India COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 42 India COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 43 India COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 44 South Korea COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 45 South Korea COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 46 South Korea COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 47 Australia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 48 Australia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 49 Australia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 50 Latin America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 51 Latin America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 52 Latin America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 53 Latin America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 54 Brazil COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 55 Brazil COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 56 Brazil COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 57 Mexico COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 58 Mexico COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 59 Mexico COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 60 Argentina COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 61 Argentina COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 62 Argentina COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 63 Colombia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 64 Colombia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 65 Colombia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 66 Middle East and Africa COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 67 Middle East and Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 68 Middle East and Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 69 Middle East and Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 70 South Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 71 South Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 72 South Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 73 Saudi Arabia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 74 Saudi Arabia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 75 Saudi Arabia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 76 UAE COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 77 UAE COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 78 UAE COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 1 List of abbreviation
Table 2 North America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 3 North America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 4 North America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 5 North America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 6 U.S. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 7 U.S. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 8 U.S. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 9 Canada COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 10 Canada COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 11 Canada COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 12 Europe COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 13 Europe COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 14 Europe COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 15 Europe COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 16 U.K. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 17 U.K. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 18 U.K. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 19 Germany COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 20 Germany COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 21 Germany COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 22 Italy COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 23 Italy COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 24 Italy COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 25 Spain COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 26 Spain COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 27 Spain COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 28 France COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 29 France COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 30 France COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 31 Asia Pacific COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 32 Asia Pacific COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 33 Asia Pacific COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 34 Asia Pacific COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 35 Japan COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 36 Japan COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 37 Japan COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 38 China COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 39 China COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 40 China COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 41 India COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 42 India COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 43 India COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 44 South Korea COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 45 South Korea COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 46 South Korea COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 47 Australia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 48 Australia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 49 Australia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 50 Latin America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 51 Latin America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 52 Latin America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 53 Latin America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 54 Brazil COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 55 Brazil COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 56 Brazil COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 57 Mexico COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 58 Mexico COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 59 Mexico COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 60 Argentina COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 61 Argentina COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 62 Argentina COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 63 Colombia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 64 Colombia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 65 Colombia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 66 Middle East and Africa COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
Table 67 Middle East and Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 68 Middle East and Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 69 Middle East and Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 70 South Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 71 South Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 72 South Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 73 Saudi Arabia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 74 Saudi Arabia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 75 Saudi Arabia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
Table 76 UAE COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
Table 77 UAE COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
Table 78 UAE COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 COVID-19 drug delivery device market, 2018
Fig. 14 COVID-19 drug delivery device market segmentation
Fig. 15 COVID-19 drug delivery device market trends
Fig. 16 COVID-19 drug delivery device market: Market driver impact
Fig. 17 COVID-19 drug delivery device market: Market restraint impact
Fig. 18 Penetration & Growth Prospect Mapping
Fig. 19 COVID-19 drug delivery device market - PESTLE Analysis
Fig. 20 Industry Analysis - Porter’s
Fig. 21 COVID-19 drug delivery device market competitive landscape: Market position analysis (Based on product, regional presence)
Fig. 22 COVID-19 drug delivery device market: Product outlook key takeaways
Fig. 23 COVID-19 drug delivery device market: Product movement analysis
Fig. 24 COVID-19 drug delivery device market: Route of administration outlook key takeaways
Fig. 25 COVID-19 drug delivery device market: Route of administration movement analysis
Fig. 26 COVID-19 drug delivery device market: Distribution channel outlook key takeaways
Fig. 27 COVID-19 drug delivery device market: Distribution channel movement analysis
Fig. 28 Regional marketplace, 2016 - 2027 (USD Million)
Fig. 29 North America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 30 U.S. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 31 Canada COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 32 Europe COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 33 U.K. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 34 Germany COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 35 France COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 36 Italy COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 37 Spain COVID-19 drug delivery device market, 2016 - 2027 (USD Million)
Fig. 38 Asia Pacific COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 39 Japan COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 40 China COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 41 India COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 42 South Korea COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 43 Australia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 44 Latin America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 45 Brazil COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 46 Mexico COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 47 Argentina COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 48 Colombia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 49 Middle East and Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 50 South Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 51 Saudi Arabia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 52 UAE COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 COVID-19 drug delivery device market, 2018
Fig. 14 COVID-19 drug delivery device market segmentation
Fig. 15 COVID-19 drug delivery device market trends
Fig. 16 COVID-19 drug delivery device market: Market driver impact
Fig. 17 COVID-19 drug delivery device market: Market restraint impact
Fig. 18 Penetration & Growth Prospect Mapping
Fig. 19 COVID-19 drug delivery device market - PESTLE Analysis
Fig. 20 Industry Analysis - Porter’s
Fig. 21 COVID-19 drug delivery device market competitive landscape: Market position analysis (Based on product, regional presence)
Fig. 22 COVID-19 drug delivery device market: Product outlook key takeaways
Fig. 23 COVID-19 drug delivery device market: Product movement analysis
Fig. 24 COVID-19 drug delivery device market: Route of administration outlook key takeaways
Fig. 25 COVID-19 drug delivery device market: Route of administration movement analysis
Fig. 26 COVID-19 drug delivery device market: Distribution channel outlook key takeaways
Fig. 27 COVID-19 drug delivery device market: Distribution channel movement analysis
Fig. 28 Regional marketplace, 2016 - 2027 (USD Million)
Fig. 29 North America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 30 U.S. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 31 Canada COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 32 Europe COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 33 U.K. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 34 Germany COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 35 France COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 36 Italy COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 37 Spain COVID-19 drug delivery device market, 2016 - 2027 (USD Million)
Fig. 38 Asia Pacific COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 39 Japan COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 40 China COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 41 India COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 42 South Korea COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 43 Australia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 44 Latin America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 45 Brazil COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 46 Mexico COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 47 Argentina COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 48 Colombia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 49 Middle East and Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 50 South Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 51 Saudi Arabia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
Fig. 52 UAE COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
